Pathway Inhibitors

Luxeptinib View larger

Luxeptinib

AOB16508

CAS 1616428-23-9

Chemical Name: CG806; CG026806; 1-(3-Fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxoisoindolin-4-yl)phenyl)-3-(2,4,6-trifluorophenyl)urea

More details

Molarity Calculation Cart®

HOW TO ORDER

$129.00

$129.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $58.05 Total: $5,805.00
150 $67.08 Total: $3,354.00
125 $78.69 Total: $1,967.25
110 $92.88 Total: $928.80
15 $109.65 Total: $548.25

Data sheet

Molecular FormulaC25H17F4N5O2
Molecular Weight495.43
CAS Numbers1616428-23-9
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymCG806; CG026806
IUPAC/Chemical Name1-(3-Fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxoisoindolin-4-yl)phenyl)-3-(2,4,6-trifluorophenyl)urea
SMILES CodeO=C(NC1=C(F)C=C(F)C=C1F)NC2=CC(F)=C(C(C=CC(C3=NC(C)=CN3)=C45)=C5CNC4=O)C=C2
References1) Ekaterina Kim MS, et al. CG-806, a First-in-Class Pan-FLT3/Pan-BTK Inhibitor, Exhibits Broad Signaling Inhibition in Chronic Lymphocytic Leukemia Cells. bloodjournal Blood blood (2019). 134 (Supplement_1) : 3051.

2) Abstract 44: CG′806, a first-in-class FLT3/BTK inhibitor, exhibits potent activity against AML patient samples with mutant or wild type FLT3, as well as other hematologic malignancy subtypes

More info

Novel potent pan-FLT3/pan-BTK inhibitor, inhibiting wild type and many of the clinically relevant mutant forms of FLT3 at low nanomolar concentrations, targeting FLT3 and clusters of kinases operative in acute myeloid leukemia